Veryan Medical Ltd. articles

PARIS, France—A "3D" helical stent that mimics the natural vascular curvature helps improve clinical symptoms and walking distance at 12 months in patients with femoropopliteal disease, according to results presented Tuesday, May 21 at EuroPCR 2013.

For the Mimics study, researchers led by Stephan H. Duda, MD, of Jewish Hospital Berlin (Berlin, Germany), randomized 76 patients with Rutherford 1to 4 occlusions of the SFA/proximal popliteal artery to receive the BioMimics 3D stent

The TCTMD reports on Timothy Sullivan`s presentation at the International Symposium on Endovascular Therapy. In terms of 12-month primary patency, the strategy of "natural swirling flow is an alternative to antiproliferative drugs," the researcher says.